S100A8 and hepatocellular carcinoma: TSPAN8, S100A8, TYRO3, LOX, and PEG10, which were upregulated in nonresponders in our study, have been identified as indicators of a poor prognosis in HCC and could promote HCC progression by multiple mechanisms, such as proliferation, invasion, and metastasis [16–18].